The requirement for prolactin in interleukin 2-driven T-cell proliferation was evaluated. Addition of an anti-prolactin antiserum resulted in the specific inhibition of T-cell proliferation in a time-and dose-dependent manner. Synthesis of prolactin and its mRNA, however, did not occur during interleukin 2 stimulation. Instead, previously internalized prolactin, presumably from fetal bovine serum, appears to serve as the source of prolactin under serum-free conditions. A 7-fold increase in a prolactin receptor occurred as a function of cell cycle progression; accumulation of a 1.6-kilobase prolactin receptor mRNA increased =2-fold. Interleukin 2 stimulation induced the translocation of prolactin into the nucleus and prolactin receptor to the nuclear periphery. These data indicate that extracellular prolactin is requisite for T-cell proliferation and suggest that the effects of prolactin are exerted in the nucleus.
The mechanisms by which interleukin 2 (IL-2) induces cell cycle progression are poorly understood (1) . It has been suggested that additional hormonal/autocrine peptides, such as transferrin (2, 3) , may act as cell cycle competency factors in concert with the interleukins. Therefore, it is reasonable to assume that other growth-related hormones may participate in IL-2-mediated cell cycle progression. One putative candidate is the neurohormone prolactin (PRL) . A growing body of evidence suggests an immunoregulatory role for this hormone. In vivo animal studies have induced lymphoid hyperplasia through the injection of PRL (4) . Conversely, a reduction of blood PRL levels by bromocryptine or hypophysectomy markedly diminished mouse T-cell responsiveness and function (5, 6) . Increased blood PRL levels have been observed in human cardiac allograft recipients undergoing acute transplant rejection (7) . At the cellular level, the presence of PRL receptors (PRLr) on the surface of human lymphocytes has been demonstrated (8) . Data also suggest that a PRL-like molecule may be secreted by lymphocytes, as such an activity has been identified in the media of a lymphoblastoid cell line (9) and concanavalin A (Con A)-stimulated splenocytes (10) . The requirement for PRL in lymphokine-and lectin-driven lymphocyte growth has been revealed (11) . Taken together, these data indicate that PRL may act as an important lymphocyte growth factor.
METHODS
Cell Culture. The murine T-helper lymphocyte clone L2 was maintained as described (12, 13) . For expansion, 106 L2 cells were cocultured with 40 x 106 irradiated allogenic murine CBA splenocytes and 400 Cetus units of highly purified recombinant human IL-2 (Cetus) in 10 ml of culture medium (13) with 10% fetal bovine serum. The L2 cells were harvested (14) and placed in culture medium without fetal bovine serum supplemented with 1% CR-ITS+ (Collaborative Research), modified after the method of Mendelsohn et al. (15) . After overnight culture the resting L2 cells were then utilized; cell proliferation was reinitiated in specific subcultures by the addition of 100 Cetus units of IL-2 per ml of chemically defined medium containing 106 L2 cells per ml.
Immunofluorescence and DNA Content Analysis. Sources of anti-PRL antiserum were Frank Talamontes (University of California, Santa Cruz), Arnel Products (New York), and the National Institute of Diabetes, Digestive, and Kidney Diseases. Rabbit anti-rat PRL was also obtained by a standard rabbit immunization protocol initially utilizing purified rat PRL with subsequent hyperimmunization with purified bovine PRL to obtain anti-bovine PRL. For the growthinhibition studies, all anti-PRL antisera gave comparable results. The anti-mouse antiserum used for immunoblot analysis has been extensively characterized and does not crossreact appreciably by radioimmunoassay with growth hormone and placental lactogens I and II (Frank Talamontes, personal communication). Mouse anti-human PRLr monoclonal antibody (16) was a gift of John Porter (University of Texas). Anti-rat PRL antiserum was further purified using a rat PRL affinity column. Cells were stained with indirect immunofluorescence (IF) and/or propidium iodide as described (17, 18) .
Immunoprecipitation and Immunoblot Analysis.
[35S]Methionine incorporation and immunoprecipitation were performed and analyzed as described (19) . Immunoblot analysis of cellular lysates and media was performed as previously (18) , using an avidin-biotin complex immunoperoxidase kit (Vector Laboratories).
Northern Blot Analysis. RNA from L2 cells was prepared for Northern blot analysis (12 16, 1989 .
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concentrations of anti-PRL or control (anti-vimentin) antiserum into the chemically defined medium of an IL-2-stimulated cloned murine T-lymphocyte line, L2. L2 cells were stimulated with IL-2 in the absence of exogenous PRL and cell cycle status was assessed at 30 hr by flow cytometric analysis of DNA content. Affinity-purified anti-PRL antiserum inhibited IL-2-induced T-cell proliferation in a dosedependent fashion (Fig. 1, open circles) . The addition of exogenous rat PRL reversed the antiproliferative effect of the afflinity-purified anti-PRL antiserum (Fig. 1, filled circle) . Neither preimmune serum (data not shown) nor irrelevant, control anti-vimentin antiserum demonstrated the inhibitory effect.
Inhibition of T-Lymphocyte Proliferation by Anti-PRL Antiserum Is Temporally Dependent. The temporal requirement for a lymphocyte-secreted PRL was examined by adding anti-PRL antiserum at various times after stimulation with IL-2 and measuring DNA content at 30 hr. Anti-PRL antiserum inhibited IL-2-driven growth when added 12 hr after culture initiation (Fig. 2 , open circles) but did not inhibit proliferation when added 18 hr or more after culture initiation. Addition of exogenous PRL into resting L2 cell culture in the absence of IL-2 ( Fig. 2 , filled circle) did not stimulate proliferation, indicating that a lymphocyte-secreted PRL is temporally necessary, but not sufficient, for proliferation.
Lymphocyte-Secreted PRL Is Not Biosynthesized by Resting or IL-2-Stimulated L2 Cells. Since it appeared that immunoreactive PRL was secreted by L2 cells, immunoblot analysis was performed on both cell lysates and concentrated cell culture media. From resting and IL-2-stimulated cultures, equal quantities of total protein from cell lysates and equal volumes of media concentrates were analyzed. A single band at -24 kDa was identified in both lysates and media concentrates ( Fig. 3A ), which comigrated with purified rat PRL and was not seen in the blot labeled with preimmune serum. Densitometric analysis of this blot revealed comparable levels of accumulated PRL in resting-and stimulated-cell lysates and a 2.5-fold increase in the extracellular PRL concentration as a function of IL-2 stimulation. Affinity Purified oxPRL (ng/ml) To determine whether L2 cells synthesized the immunoreactive PRL species, biosynthetic labeling with [35S]methionine followed by immunoprecipitation using anti-PRL (or control) antiserum was performed. Attempts to demonstrate an 35S-labeled lymphocyte PRL were not successful. Immunoreactive PRL was revealed by immunoblot analysis of the immunoprecipitates with anti-PRL antiserum (Fig. 3B , panels a and b). Subsequent autoradiography of the electrophoretically transferred proteins (Fig. 3B, panels c and d) showed that the antigenically detectable PRL was not radiolabeled.
Uptake of exogenous bovine PRL from the fetal bovine serum-containing culture medium used during maintenance culture could account for the intracellular pool of PRL within L2 cells. To examine this possibility, L2 cell lysates and purified rat, mouse, and bovine PRL were blotted onto nylon membranes. These blots were then labeled either with crude anti-PRL antiserum or with anti-PRL antiserum that had been affinity-purified using Sephadex-conjugated bovine PRL. Crude anti-PRL antiserum labeled all species of PRL, whereas the affinity-purified antiserum recognized only bovine PRL and the PRL within L2 cells (Fig. 3C) .
PRLr mRNA, But Not PRL mRNA, Is Expressed in Resting, IL-2-, and Con A-Stimulated L2 Cells. Steady-state levels of PRL and PRLr mRNA were determined in resting, IL-2-, and Con A-stimulated L2 cells (Fig. 4) (Fig. 6A) , a perinuclear cytoplasmic pool of PRL was seen with little to no apparent anti-PRL IF noted within the nucleus. In contrast, in IL-2-stimulated L2 cells significant levels of anti-PRL IF were noted within the nucleus (Fig. 6B) . As an antibody specificity control, exogenous PRL was added with anti-PRL antiserum; this reduced IF to background levels ( Fig. 6 C and D) , demonstrating the specificity of the anti-PRL IF. Similarly cells stained with preimmune serum demonstrated low levels of nonspecific staining (data not shown).
Anti-PRLr IF revealed the presence of PRLr on the cell surface and within the cytoplasm of L2 cells (Fig. 6 E and F) . Stimulation with IL-2 led to a partial translocation of the PRLr to the nuclear periphery of L2 cells. It is uncertain, given the limited resolving powers of IF microscopy, whether 
DISCUSSION
Although the interaction of IL-2 and the IL-2 receptor has been well characterized, the mechanisms surrounding the signal transduction of this event, and the subsequent induced expansion of T cells, remain poorly understood. Many of the factors associated with T-cell activation, such as protein phosphorylation/protein kinase activation (21, 22) and Ca', K+, and H+ concentrations (23, 24) , have been extensively studied in IL-2-dependent T-cell lines. To date, however, no single intracellular transduction molecule has been conclusively demonstrated to mediate directly cell cycle progression in T cells binding IL-2 (1). Alternatively, the coordinate secretion and/or uptake of lymphokines and hormonal factors, such as PRL, might trigger the cascade of intra-and extracellular events that mediate cell cycle progression (2) .
We demonstrate here that the extracellular secretion of PRL by L2 cells is required for their proliferation in chemically defined medium. This was shown by the specific and (28) . The PRL-PRLr complex in these tissues is translocated into the Golgi apparatus, endosomes/ secretory granules, and the cell nucleus (25, (29) (30) (31) .
The continued study of PRL-mediated, IL-2-induced T-cell proliferation should provide further insights into the neurohormonal mechanisms of lymphocyte growth regulation. Further characterization of the cellular channeling and recycling of PRL, and the molecular events triggered by these events, may prove central to a complete knowledge of the molecular cascade that ultimately leads to clonal T-cell expansion.
